Nortran Pharmaceutical -NRT.V Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Nortran Pharmaceutical -NRT.V

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Wisee who wrote (647)	5/11/1998 11:10:00 AM
From: Mr. Forthright	Read Replies (1) of 1185

<< Vancouver, May 7/CNW/ - Nortran Pharmaceuticals Inc. advises that story number c1678 F. Hoffman-LaRoch and Nortran sign agreement to develop drugs for treatment of atrial arrhythmias transmitted at 14:48e today was sent in error and should not be used. Please disregard item.>> What does that mean? Did the IR department pull the trigger too quickly? I wonder what Hoffmann thinks of this? Should investors also <<disregard item>>?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next